|
NDFIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58761892521397E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7537082896979E-12 |
| Normal-vs-Stage2 |
4.81190000067855E-08 |
| Normal-vs-Stage3 |
9.37399999956234E-07 |
| Normal-vs-Stage4 |
2.24819999999903E-05 |
| Stage1-vs-Stage2 |
7.489000E-01 |
| Stage1-vs-Stage3 |
6.511800E-01 |
| Stage1-vs-Stage4 |
5.672600E-01 |
| Stage2-vs-Stage3 |
9.393000E-01 |
| Stage2-vs-Stage4 |
6.987400E-01 |
| Stage3-vs-Stage4 |
7.883800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64546154479694E-12 |
| Normal-vs-AfricanAmerican |
7.96110000145234E-09 |
| Normal-vs-Asian |
3.186400E-01 |
| Caucasian-vs-AfricanAmerican |
8.301700E-02 |
| Caucasian-vs-Asian |
9.564300E-02 |
| AfricanAmerican-vs-Asian |
3.627600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63136171238421E-12 |
| Normal-vs-Female |
1.02170000015889E-07 |
| Male-vs-Female |
2.236500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.15150000038022E-08 |
| Normal-vs-Extreme_Weight |
4.77395900588817E-14 |
| Normal-vs-Obese |
1.37030387037385E-11 |
| Normal-vs-Extreme_Obese |
2.618700E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.008400E-01 |
| Normal_Weight-vs-Obese |
9.140600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.400600E-01 |
| Extreme_Weight-vs-Obese |
3.845400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.455600E-01 |
| Obese-vs-Extreme_Obese |
6.188200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.82409999958256E-07 |
| Normal-vs-Age(41-60Yrs) |
1.0815015549781E-11 |
| Normal-vs-Age(61-80Yrs) |
1.62825308791525E-12 |
| Normal-vs-Age(81-100Yrs) |
1.17929999987609E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.546400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.567400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.601800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.423800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.263200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.063600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62980740014973E-12 |
| Normal-VS-Type2 PRCC |
3.59910001801467E-09 |
| Normal-VS-KIRP CIMP |
1.02570000004576E-06 |
| Normal-VS-Unclassified PRCC |
1.0463000021943E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.763980E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.599000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.599800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.272000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.210200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.422400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.17840215152887E-11 |
| Normal-vs-N1 |
4.81379999972553E-07 |
| Normal-vs-N2 |
2.204400E-03 |
| N0-vs-N1 |
2.660600E-01 |
| N0-vs-N2 |
6.495000E-01 |
| N1-vs-N2 |
9.386600E-01 |
|
|
